A

Achieve Life Sciences

D
ACHV
USD
-0.08
(-1.5717%)
Market Closed
2,557.00
Volume
-0.92
EPS
-
Div Yield
-4.682243
P/E
172,049,928.03
Market Cap
Today
-1.5717%
1 Week
6.823%
1 Month
-2.718%
6 Months
5.474%
12 Months
18.720%
Year To Date
19.002%
All Time
0%

Title:
Achieve Life Sciences

Sector:
Healthcare
Industry:
Biotechnology
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Do you need help or have a question?